Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, Follicular × Dasatinib × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myelogenous, Chronic, BCR-ABL Positive 3 Burkitt Lymphoma 3 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1 Philadelphia Chromosome 1 Pancreatic Neoplasms 1 Neuroblastoma 1 Neoplasm, Residual 1 Myeloproliferative Disorders 1 Multiple Myeloma 1 Lymphoma, Non-Hodgkin 1 Leukemia, Myeloid, Chronic-Phase 1 Leukemia, Myeloid, Acute 1 Brain Neoplasms 1 Blast Crisis 1

Interventions

Rituximab 15 Cyclophosphamide 14 Lenalidomide 12 Prednisone 9 Vincristine 8 Doxorubicin 8 obinutuzumab 5 fludarabine 5 Specimen Handling 5 Magnetic Resonance Spectroscopy 5 R-CHOP protocol 4 Biopsy 4 Bendamustine Hydrochloride 4 zanubrutinib 3 ibrutinib 3 fludarabine phosphate 3 tisagenlecleucel 2 tazemetostat 2 Whole-Body Irradiation 2 Temozolomide 2 Radiotherapy 2 Prednisolone 2 Oxaliplatin 2 Gemcitabine 2 Cyclosporine 2 CT-P10 2 voruciclib 1 venetoclax 1 umbralisib 1 treosulfan 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡